Healthcare >> CEO Interviews >> October 26, 2004
GREG COLLIER is Managing Director and Chief Executive Officer of
ChemGenex Pharmaceuticals Ltd. He has a BSc (hons) and PhD. Dr. Collier
is an international expert in the field of diabetes and obesity and one
of Australia's leading authorities in the field of biotechnology. Since
joining the company as an executive in 2000, Dr. Collier has guided the
company's research and positioned it to be competitive both in Australia
and internationally. Dr. Collier was instrumental in negotiating the
commercial alliances with Merck Sant and Vernalis as well as the merger
transaction with ChemGenex Therapeutics Inc., and maintains oversight of
research and corporate initiatives within the company. Profile
the things you are doing at the present time.
Dr. Collier: ChemGenex Pharmaceuticals is the result of a merger
